Treatment Options for Low or Absent Sperm Production
The treatment approach depends entirely on whether the cause is obstructive versus non-obstructive azoospermia, with surgical sperm retrieval combined with ICSI being the definitive option for most cases, while medical therapy is reserved for specific reversible conditions like hypogonadotropic hypogonadism or varicocele. 1
Diagnostic Classification Determines Treatment Path
The first critical step is distinguishing obstructive from non-obstructive causes, as this fundamentally changes management 1:
Obstructive azoospermia indicators:
- Normal testicular size and consistency on examination 1
- FSH levels typically <7.6 IU/L 1
- Low ejaculate volume (<1.4 mL) with acidic pH (<7.0) suggests distal obstruction 1, 2
- Dilated/indurated epididymides or absent vas deferens on exam 1
Non-obstructive azoospermia indicators:
- Testicular atrophy on physical examination 1, 3
- FSH levels >7.6 IU/L 1, 3
- Normal semen volume and pH 3
Treatment Options by Etiology
For Obstructive Azoospermia
Ejaculatory duct obstruction (EDO):
- Transurethral resection of ejaculatory ducts (TURED) is the primary surgical option to restore natural fertility 1, 4
- Confirm diagnosis with TRUS or pelvic MRI showing seminal vesicle diameter >15 mm, ejaculatory duct caliber >2.3 mm, or prostatic cysts 1, 4
- If TURED fails or is declined, proceed to testicular sperm extraction (TESE/TESA) with ICSI 1
Congenital bilateral absence of vas deferens (CBAVD):
- No medical or surgical treatment restores ejaculatory volume 2
- Proceed directly to microsurgical epididymal sperm aspiration (MESA) or TESE with ICSI 1, 2
- Critical: CFTR gene testing for the female partner is mandatory before assisted reproduction 2
Post-vasectomy or acquired obstruction:
- Microsurgical reconstruction (vasovasostomy or epididymovasostomy) is preferable when the female partner has normal fertility potential 1
- Alternatively, sperm retrieval with ICSI is an option 1
- Avoid epididymal sperm retrieval if future microsurgical reconstruction might be pursued due to scarring risk 1
Clinical varicocele:
- Varicocelectomy improves semen parameters and may restore sperm in ejaculate for men with azoospermia, particularly with hypospermatogenesis on histology 2
- Treatment is indicated only for palpable varicoceles with abnormal semen parameters 2
- Avoid this pitfall: Subclinical (non-palpable) varicoceles detected on ultrasound should not be treated—they do not improve outcomes 2
For Non-Obstructive Azoospermia
Surgical sperm retrieval:
- Microdissection TESE (micro-TESE) is 1.5 times more successful than conventional TESE and 2 times more likely to yield sperm than testicular aspiration 1
- Up to 50% of men with non-obstructive azoospermia have retrievable sperm despite elevated FSH 3
- Retrieved sperm is used with ICSI for fertilization 1
Medical therapy has extremely limited role:
- Patients with non-obstructive azoospermia should be informed of limited data supporting pharmacologic manipulation with SERMs, aromatase inhibitors, and gonadotropins prior to surgical intervention 1
- These medications are not FDA-approved for this indication and benefits are questionable 1
For Hypogonadotropic Hypogonadism
This is the one scenario where medical therapy can restore spermatogenesis:
- Evaluate to determine the etiology of the condition and treat based on diagnosis 1
- Human chorionic gonadotropin (hCG) 500-1,000 USP units three times weekly for 3 weeks, followed by the same dose twice weekly for 3 weeks 5
- Alternative regimen: 4,000 USP units three times weekly for 6-9 months, then reduce to 2,000 USP units three times weekly for 3 additional months 5
- FSH analogues may be added if sperm counts remain low after testosterone normalizes on hCG 3
- Critical warning: Never prescribe testosterone monotherapy to men desiring fertility—it suppresses spermatogenesis through negative feedback and can cause azoospermia 1, 3
For Oligospermia (Low Sperm Count)
Medical options with limited evidence:
- Aromatase inhibitors, hCG, or selective estrogen receptor modulators (SERMs) may be used for infertile men with low serum testosterone 1
- FSH analogues may improve sperm concentration, pregnancy rate, and live birth rate in idiopathic infertility, but benefits are limited 1
- Clinicians should inform men with idiopathic infertility that the use of SERMs has limited benefits relative to results of ART 1
- Supplements (antioxidants, vitamins) are of questionable clinical utility with inadequate data for specific recommendations 1
Assisted reproductive technology:
- For low total motile sperm count on repeated semen analysis, IUI success rates are reduced and IVF/ICSI should be considered 1
- IVF treatment allows for 37% live delivery rate per initiated cycle 1
- Success decreases with increasing female age (>35 years) 1
Mandatory Genetic Testing Before Treatment
Before proceeding with sperm retrieval and ICSI:
- Karyotype testing is required for primary infertility with azoospermia or sperm concentration <5 million/mL when accompanied by elevated FSH, testicular atrophy, or impaired sperm production 1
- Y-chromosome microdeletion screening is mandatory for azoospermic men with suspected impaired sperm production and severely oligospermic men with sperm concentrations <1 million/mL 1
- Complete AZFa and AZFb deletions have almost zero likelihood of sperm retrieval and contraindicate TESE 3
- Genetic counseling should precede ICSI as genetic abnormalities may be transmitted to offspring 2
Critical Pitfalls to Avoid
Do not perform routine imaging without clear indication:
- TRUS or pelvic MRI should be reserved for cases with clear clinical suspicion of EDO (low volume, acidic, azoospermic semen with normal testosterone and palpable vas) 2, 4
- Routine scrotal ultrasound to hunt for subclinical varicoceles is discouraged—only palpable varicoceles warrant treatment 1, 2
Do not delay genetic testing:
- Results impact counseling and treatment decisions before proceeding with assisted reproduction 2
Do not prescribe testosterone for fertility: